Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction.

Suzuki S, Yamamoto M, Sanomachi T, Togashi K, Sugai A, Seino S, Yoshioka T, Kitanaka C, Okada M
Cancers (Basel). 2019 Jul 5;11(7). pii: cancers11070947. doi: 10.3390/cancers11070947. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.